drugset / Trial / NCT07551570
Pharmacokinetics of VC005 Tablets in Subjects With Renal Impairment and Normal Renal Function
Non-randomizedParallel-groupOpen-labelTreatment
Summary
This study is a Phase I, single-dose, open-label trial designed to evaluate the pharmacokinetics and safety of a single oral dose of 25 mg VC005 tablets in participants with renal impairment compared to participants with normal renal function.
Timeline
- Start
- 2026-05-09
- Primary completion
- 2026-10-30
- Completion
- 2026-10-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | VC005 | Unknown | 25 mg | Oral |